Clerico, M., Faggiano, F., Palace, J., Rice, G., Tintorè, M., & Durelli, L. (2008). Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
Citación estilo ChicagoClerico, M., F. Faggiano, J. Palace, G. Rice, M. Tintorè, and L. Durelli. Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis. 2008.
Cita MLAClerico, M., et al. Recombinant Interferon Beta or Glatiramer Acetate for Delaying Conversion of the First Demyelinating Event to Multiple Sclerosis. 2008.
Warning: These citations may not always be 100% accurate.